Please login to the form below

NDA

NDA is Europe’s leading regulatory affairs consultancy, providing clients with a unique insight into EU regulatory thinking and the best possible expert guidance and support to optimise the time to the European market. Year on year, NDA has contributed towards more than 30% of new medicinal products receiving CHMP opinions, through strategic advice and operational support.

This is a FREE listing




Below are full profiles from other companies in this area

Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer.

View profile

Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making connections with clients and research participants alike. Flexibility, creativity and the desire to do what is right for your business drive what we do.

View profile

Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life visit SyneosHealth.com.

View profile

Company Details

NDA

Telephone:+44 1372 860610

Address:
Prime House
Challenge Court , Barnett Wood Lane
Leatherhead
Surrey
KT22 7DE
United Kingdom

Latest content from PMHub

RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use real-world data cautiously. In our third instalment, we’re looking at how to find the right balance in using RWE.
Valid Insight
What do Healthcare Professionals think about the inclusion of remote selling techniques?
Evolving to a digitally focused pharma / healthcare company - an organisational roadmap
OUTiCO
Insights from non-healthcare marketing: Brand Activism – does it have a role in Pharma?
Increasingly consumers are demanding that brands be more active – that they not only stand for something, but they do something about it. Bedrock Group
Publication planning excellence at Porterhouse Medical
Porterhouse Medical Group